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VACCINATION FOR NEWLY EMERGED INFECTIOUS DISEASES AS A BLESSING
OR CURSE FROM THE PERSPECTIVE OF THE LEBANESE POPULATION: A TWOPHASE STUDY
Abstract
Although vaccination campaigns have been vital in mitigating the spread of many pandemics, false
information about COVID-19 vaccine through social media might have a negative impact on its acceptance.
In Lebanon, prior to the vaccination campaign, the acceptance rate of COVID-19 vaccination did not
exceed 20 %. In the current study, the acceptance of vaccination by Lebanese participants was studied
following the launching of the vaccine. The aim of the work is to reveal the actual intention of the
studied sample once the vaccine is available and investigate the change in the perception and acceptance
rate of Lebanese citizens about vaccination as influenced by many factors over time. A cross-sectional
questionnaire-based study was conducted in two separate phases (March 2021 and May 2021). In the first
phase, the questionnaire included socio-demographic data and reasons for vaccine’s refusal. In the second
phase, 2 sections were added, addressing the change in the attitude of participants towards vaccination,
and the reasons behind this change. Data were analyzed using SPSS-version 20 and the results were
considered statistically significant with p values ≤0.05. In both phases, the willingness to take the vaccine
did not significantly change (p>0.05). Although 80 % of participants consider vaccination important, only
50 % of the studied sample were willing to take the vaccine. Such findings confirm hesitancy that can be
attributed to worries about long-term effects and incomplete information about the safety and efficacy
of the vaccine. Therefore, awareness campaigns about false beliefs should be extensively conducted,
with more emphasis on tailored education for special subpopulations, and other measures should be
implemented more efficiently (e.g. restricted access to public places for unvaccinated individuals) to
accelerate the vaccination rate.
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1. INTRODUCTION
The spread and evolvement of coronavirus species (i.e. SARS CoV and MERS CoV) pose
a high risk to public health (de Wit et al., 2016). Recently, new species have evolved, namely,
SARS-CoV-2, resulting in around half a billion infected cases, and nearly 6 million deaths that
were documented globally (WHO, 2022). In addition to the threats of the disease named COVID19 and its impact on the health system, it has brought economic burden and social disorder by
disrupting communications on both national and international levels (Nicola et al., 2020).
COVID-19 has spread rapidly to be declared a pandemic by the World Health Organization
in March 2020. The symptoms ranged from mild ones, such as fever, fatigue, cough, sore throat,
and loss of taste and smell, to more severe ones such as pneumonia. The severity of the disease
can lead to multi-organ failure namely; cardiovascular, kidney, and liver. Moreover, neurologic
complications as well as thrombosis have been detected (Tsai et al., 2021). Furthermore, other
comorbidities such as chronic lung disease, cardiovascular disease, hypertension, obesity, and
diabetes are linked to a poor prognosis (Fadlallah et al., 2022; Gebru et al., 2021; Noureddine et
al., 2021). The susceptibility to SARS-CoV-2 increases with age, where older age is associated
with increased disease morbidity and mortality (Fadlallah et al., 2022; Gebru et al., 2021).
Consequently, the burden of COVID-19 has increased drastically to include over 450 million
confirmed cases worldwide and around one million cases in Lebanon with more than ten thousand
deaths by March 2022 (WHO, 2022).
The sustainable success of health systems to cease this pandemic depends on extensive
vaccination campaigns (Adhami et al., 2021; Bhattacharya et al., 2020; Saha et al., 2020).
Nevertheless, the disease outbreak is coinciding with an apparent mistrust regarding COVID-19
vaccines (Abdul & Mursheda, 2020). Findings from previous studies that were conducted in
different countries revealed the refusal of vaccination by more than 25 % of the population
(Neumann-Böhme et al., 2020; Peretti-Watel et al., 2020; Thunström et al., 2021). The spread of
misinformation through social media might have contributed to the skepticism clouding the
vaccines (Abdul & Mursheda, 2020). Most identified concerns include uncertainty about the
novelty and safety of COVID-19 vaccines as well as worries about its potential side effects
(Neumann-Böhme et al., 2020; Rhodes et al., 2021; Sherman et al., 2021; Williams et al., 2020).
In Lebanon, a previous study has been conducted to investigate the acceptance rate of COVID-19
vaccination. The study revealed a vaccination acceptance rate of around 20 % by the Lebanese
population (Al Halabi et al., 2021). However, the data was collected during a period preceding the
start of the vaccination program in the country (November 2021) which rose the doubt about the
vaccine safety and efficacy. In the current work, the attitude and perception of Lebanese
population towards COVID-19 vaccines were studied after launching the national vaccination
program, in 2 separate phases. The aim of the work is to investigate the change with time in the
perception and acceptance rate of Lebanese citizens about vaccination as influenced by the
educational campaigns, the change of their social cognitive behavior that would be influenced by
the vaccination experience as perceived by their relatives and friends, and other factors.

2. METHODOLOGY
A cross-sectional anonymous questionnaire was designed in March 2021 targeting
Lebanese people living in all 5 areas of Lebanon (Beirut, North, South, Beqaa, and Mount
Lebanon). The sample size was calculated using “Raosoft®” online tool assuming a total
population of 6.825 million. The results revealed that a sample size equal or above 384
participants represents the population, considering a 5% error and 95% confidence level. Data
was collected over 2 phases; the first phase was carried out in March 2021, whereas the second
phase took place in May 2021. Confidentiality and autonomy of participants were respected, and
an informed consent was given by those who filled the survey. Accordingly, the study was
exempted from ethical approval. Due to COVID-19 restrictions and preventive measures, the
study was carried out using google form, and the link was shared on WhatsApp. The
questionnaire was designed in both English and Arabic languages (the latter is native language
in Lebanon), where both forms were available to choose between. As a first step, the survey
validity was evaluated by three experts. In the second step, a pilot study was carried out on 20
participants. The collected data helped to check for readability and comprehension of the survey
and was excluded from the study. According to the collected feedback, the questionnaire was
Published by Digital Commons @ BAU, 2022
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revised and modified. In the first phase, the survey was divided into 2 sections; The first section
consisted of sociodemographic questions. In the second section, the participants were asked if
they have already taken the vaccine, followed by justifying the reason to not taking it. In the
survey of the second phase, 2 additional sections were added to the previous ones. The third
section addressed the change of attitude of participants towards the vaccination, and the fourth
section stated the reasons behind this change. In the second and fourth section of the survey, the
participants had the option to choose more than one answer. Statistical analysis was carried out
using Statistical Package for the Social Science software (SPSS®) version 20. Data were
expressed as frequencies and percentages.

3.

RESULTS AND DISCUSSION
In the first phase, 565 participants responded to the survey. Out of which 68.1% were
female. Age of less than 30 years accounted for 63.9%. More than two-third of the respondents
had a university degree (71.0 %), around one-third were employed (30.1 %) and 62% did not
have any medical background. Most of the respondents were non-smokers (66.7%), and avowed
having a normal weight (65.5 %). The investigation about the health condition of the studied
sample has revealed that only 21.4 % of the participants had past medical history. The highest
percentage of the studied sample (35.4 %) lived in Beirut area (the capital of Lebanon). In the
second phase, the survey link was sent to the same respondents of phase 1, yet, only 277
participants have responded, where the demographic characteristics were quite similar to those
of the previous phase.
Table 1: Demographic characteristics of the studied samples in phase 1 and phase 2
Characteristic

Phase 1*
Frequency (%)

Phase 2**
Frequency (%)

Male
female

180 (31.9)
385 (68.1)

108 (39.0)
169 (61.0)

18-29
30-49
50-59
60-69
>70

361 (63.9)
120 (21.2)
48 (8.5)
24 (4.2)
12 (2.1)

153 (55.2)
63 (22.7)
33 (11.9)
19 (6.9)
9 (3.2)

Uneducated
Middle school
High school
University degree
Diploma (BT/TS)

4 (0.7)
44 (7.8)
88 (15.6)
401 (71.0)
28 (5.0)

3 (1.1)
26 (9.4)
51 (18.4)
179 (64.6)
18 (6.5)

Student
Employed
Unemployed
Retired

289 (51.2)
170 (30.1)
86 (15.2)
20 (3.5)

130 (46.9)
84 (30.3)
48 (17.3)
15 (5.4)

Medical
Non-medical

212 (37.5)
353 (62.5)

119 (44.4)
149 (55.6)

Smoker
Ex-Smoker
Non-Smoker

146 (25.8)
42 (7.4)
377 (66.7)

83 (30.0)
18 (6.5)
176 (63.5)

Obese
Overweight
Normal
Underweight

23 (4.1)
137 (24.2)
370 (65.5)
35 (6.2)

13 (4.7)
62 (22.4)
189 (68.2)
13 (4.7

Yes
No

121 (21.4)
444 (78.6)

68 (24.5)
209 (75.5)

Gender

Age (years)

Educational level

Employment

Medical background

Smoking

Obesity

Comorbidities

Residency
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Characteristic
Beirut
North
South
Beqaa
Mount Lebanon

Phase 1*
Frequency (%)
200 (35.4)
77 (13.6)
134 (23.7)
21 (3.7)
133 (23.5)

Phase 2**
Frequency (%)
121 (43.7)
19 (6.9)
56 (20.2)
26 (9.4)
55 (19.9

*N= 565
**N=277

Fig.1:Vaccine intake by respondents. (a) Phase 1, (b) Phase 2

In the first phase, the majority of participants (91.5%) did not take the vaccine (Figure 1).
The main rationale behind not taking the vaccine was that more than half of these
respondents (56.8 %) were still waiting their turn for vaccination, whereas, the rest (43.2 %) have
refused vaccination for other reasons (Table 2). An earlier study conducted in Lebanon just
before the release of the vaccine, revealed that around 20 % of the Lebanese population were
willing to get vaccinated (Al Halabi et al., 2021). Interestingly, in the present study, positive
responses toward vaccination were higher than those of the preceding study. The current work
showed the actual intention of participants to be vaccinated at a time when vaccines were already
available.
Reasons of vaccination refusal that were most frequently encountered during the first
phase include their concerns about the safety and efficacy of the vaccine (21.5 % and 13.1 %,
respectively), and to lesser extent their belief of acquiring a good immune system (4.3 %), being
pregnant or breastfeeding (1.1 %), and others (Table 2). Likewise, earlier studies have reported
that concerns about vaccine safety and efficacy were the main reasons for refusal of vaccination
against any newly evolving infectious disease (Determann et al., 2014; Fisher et al., 2020; Lin
et al., 2021; Neumann-Böhme et al., 2020) .
It is noteworthy to mention that the limited knowledge and the spread of false information
through the media might have contributed in increasing uncertainty toward vaccination (Fisher
et al., 2020; Kourlaba et al., 2021; Loomba et al., 2021). Moreover, multiple deaths of vaccinated
individuals have been reported in several countries making people anxious about the vaccine and
its side effects.
When it comes to the vaccine efficacy, concerns would be mainly attributed to a bad
experience of COVID-19 vaccination as perceived by relatives and friends. In one study, the
mistrust about yearly flu vaccine efficacy was investigated. Findings revealed that some people
had concerns about flu vaccine’s safety as, although being vaccinated, they have had upper
respiratory tract infections (Cowling et al., 2012).
In the second phase, the percentage of participants who did not take the vaccine dropped
remarkably to 70.7 % (figure 1b). This would be attributed to the intake of the vaccine by some
of the participants who were willing to get vaccinated in the first phase, yet, they were still
waiting for their turn (15.5 %). When justifying the reasons behind not taking the vaccine, the
statistical data (odd’s ratio) did not reveal any significant difference in their responses in both
phases (p>0.05), with the exception of the following responses stating “I have a good immune
Published by Digital Commons @ BAU, 2022
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system” and “I am pregnant or breastfeeding” (Table 2). The aforementioned two reasons of
refusing the vaccine were more frequently stated by respondents in the second phase, recording
a significantly higher response rate (13.9 % vs 4.3 % for having a good immune system, and 11.5
% vs 1.1 % for being pregnant or breastfeeding) with a p value of less than 0.001.
Table 2: Reasons behind not being vaccinated in the two phases of the study
Reason
I am willing to take it and I am
waiting my turn
I have a good immune system
I got infected previously and I
acquired the immunity
I am concerned about the
vaccine efficacy
I am concerned about the
vaccine safety
I am pregnant or breastfeeding
I am religious and God will
protect me
I don’t feel I am at risk
I believe that this pandemic
will end very soon by its own
*N=288
**N=195
Chi square test done
Odds for phase 1/phase 2

Phase 1*
Frequency (%)
209 (56.8)

Phase 2**
Frequency (%)
83 (50.3)

P value

OR (CI)

0.164

0.770 (0.533-1.113)

16 (4.3)
23 (6.3)

23 (13.9)
16 (9.7)

0.000
0.158

3.563 (1.829-6.944)
1.611 (0.827-3.136)

49 (13.3)

24 (14.5)

0.703

1.108 (0.654-1.877)

79 (21.5)

29 (17.6)

0.335

0.793 (0.494-1.272)

4 (1.1)
4 (1.1)

19 (11.5)
5 (3.0)

0.000
0.108

11.810 (3.950-35.309)
2.836 (0.752-10.700)

16 (4.3)
16 (4.3)

9 (5.5)
11 (6.7)

0.576
0.252

1.269 (0.549-2.935)
1.582 (0.717-3.488)

In the second phase, the change in attitude towards COVID-19 vaccination was
investigated by asking the participants about the importance of vaccination (Table 3). Around
half of the participants (132, 47.7 %) have responded that they consider the vaccination important
since the beginning of the campaign, whereas, about one-third of respondents (91, 32.9 %) were
not initially convinced about its importance but they changed their mind.
Table 3: Attitude toward the vaccine (Phase 2)
Importance of the vaccine
Yes, since the beginning of the vaccination campaign
No, since the beginning of the vaccination campaign
I was not convinced at the beginning but I have changed my mind and I am currently
convinced about its importance
I was convinced at the beginning but I have changed my mind and I am not currently
convinced about its importance
N=277

Phase 2
Frequency (%)
132 (47.7)
43 (15.5)
91 (32.9 %)
11 (3.9 %)

The reasons behind the positive attitude of participants’ toward COVID-19 vaccination
was investigated (Table 4). It was found that the highest percentage of respondents (47.7 %) have
been convinced by health care providers, including their physicians and pharmacists. Moreover,
the influence of the educational campaigns via social media and television was also remarkable
(36.4 %), as well as good experience of vaccination as perceived by friends and family (34.1 %).
Other less frequently encountered reasons include the inability of the participants to withstand
quarantine and social distancing, and their fear to be forbidden from traveling if unvaccinated
(20.4 % and 15.9 %, respectively). Surprisingly, none of the participants related their attitude
change, and, hence, conviction about the vaccination, to receiving news about death cases due
to COVID-19 infection. This would be mainly attributed to the low death rate in Lebanon (~ 1
%), according to the number that has been reported to WHO and published to this date (WHO,
2022).
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Earlier studies have reported that people used multiple resources to receive health
information about COVID-19 infection, as such resources would help in changing the attitude
and perception of people about vaccination and contribute to the decision-making process to
accept or refuse the vaccination (Ali et al., 2020). Healthcare providers have proven to be a
trustful source of information; in a study conducted in France, MMR- and HBV-vaccine
acceptance rates by parents were higher when they received the information from health care
providers rather than from the internet or relatives (Charron et al., 2020). In another study
conducted in South Carolina, 74 % of participants were convinced to take COVID-19 vaccine
after receiving relevant information and education from their healthcare providers (Qiao et al.,
2020).
Table 4: Reasons behind the positive change of participants’ attitude toward the vaccine
Reason
A good experience of COVID-19 vaccination as perceived by
relatives and friends
Educational Campaigns (social media, TV)
Health care providers advise
I am afraid that if being unvaccinated I would be forbidden
from travelling
Can no longer withstand social distancing and quarantine
N=91

Phase 2
Frequency (%)
30 (34.1 %)
32 (36.4%)
42 (47.7 %)
14 (15.9 %)
18 (20.4 %)

Although the vaccine is considered important for around 80 % of the studied sample
during phase 2, only 50.3 % of the respondents were willing to take it. This would be explained
by the significant increase in the number of participants who believe in acquiring a good immune
system and those who are pregnant or breastfeeding mothers. Although COVID-19 infection
would increase the risk of premature birth (Khoury et al., 2020), and sometimes the death of the
fetus (Popescu et al., 2021), the lack of studies about COVID-19 vaccination in pregnant and
breastfeeding women during the early stages of vaccination campaigns might have arisen the
concerns about its safety and efficacy and consequently contributed to the hesitancy of its intake.
Therefore, reliable information from healthcare providers and most particularly gynecologists
on the safety and effectiveness of the vaccination would contribute to reducing their anxiety
(Januszek et al., 2021). Moreover, public health campaigns that stress the preventive role and
safety of the vaccine rather than the risk of the infection itself would be beneficial among this
category of the population (Chervenak et al., 2021).
When analyzing the participants’ response ‘I have a good immune system’, we may
attribute such findings to their healthy status and practicing a healthy lifestyle. In addition, these
participants would have been consuming immune-boosting supplements (magnesium, zinc,
vitamin C, D, and E) that would prevent and fight against COVID-19 infection (Arshad et al.,
2020). Even though such information was supported by some research, yet, most of the studies
were carried out in-vitro, hence, lacking clinical evidence (Galanakis et al., 2020).
Despite the fact that some of the aforementioned factors may have played a role in the
decision-making of the Lebanese population to refuse the vaccine, more than half of
unvaccinated people were waiting their turn to be called for vaccination. Since the launching of
the COVID-19 vaccine in Lebanon, educational campaigns were conducted in the country to
raise awareness about its importance, which was supported by the advice of healthcare providers.
The phases of the study were separated by a two-month period hence, the insignificant change
in the response of participants toward vaccination would be attributed to their concern about the
long-term effects of the vaccine, and the lack of evidence-based information about its safety in
specific populations at that time. The willingness of around half of the unvaccinated Lebanese
population to get the vaccine has been translated into the increasing number of vaccinated cases
in Lebanon that recorded approximately 1 % at the beginning of the vaccination campaign,
reaching 7.5 % after two months, and approaching 40 % of the population during March 2022.
On the other hand, countries such as United Arab Emirates, Singapore, France and united states
have reported higher vaccination rates attaining 99%, 91 %, 80 %, and 76 %, respectively (Our
World in Data, 2022).
Published by Digital Commons @ BAU, 2022
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4. CONCLUSION AND RECOMMENDATIONS
As a conclusion, even though 80% of the studied sample consider COVID-19 vaccination
important to prevent the spread of the disease, only 50% were willing to be vaccinated which was
influenced by the false information received from social media. Consequently, awareness
campaigns about false beliefs should be more extensively conducted to reduce the concerns of the
population toward newly developed vaccines. In addition, more emphasis on tailored education
should be spent for special subpopulations such as pregnant, breastfeeding women, and children.
Although recently, unvaccinated individuals are not allowed to travel, other measures should be
taken more seriously to hasten the vaccination rate in Lebanon (only ~40 % till this date when
compared to ~65 % worldwide), such as restricted access to public places for those who do not
acquire a vaccination certificate.

5. LIMITATIONS
Due to COVID-19 protective measures, the questionnaire was circulated through email and
WhatsApp. Consequently, WhatsApp consisted the main limitation of the study, although it
included a large number of participants. The team was eager to spread the survey to all
socioeconomic classes; however, illiterate people or those without mobile phones or computers
may have been underrepresented. Moreover, participants were partially enrolled in the second
phase, hence reducing the sample size, which may have affected the findings of the study.
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